Barclays PLC Seelos Therapeutics, Inc. Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $8,133 - $14,831	-15,948 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $86,764 - $176,627	-103,291 Reduced 86.63%	15,948 $13,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $125,757 - $188,241	79,093 Added 197.01%	119,239 $195,000
Q3 2021 Nov 09, 2021	SELL	$1.69 - $2.89 $32,890 - $56,245	-19,462 Reduced 32.65%	40,146 $97,000
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $154,725 - $370,402	58,608 Added 5860.8%	59,608 $157,000
Q1 2021 May 13, 2021	BUY	$1.35 - $4.99 $1,350 - $4,990	1,000 New	1,000 $5,000
Q3 2020 Nov 12, 2020	SELL	$0.6 - $1.25 $160 - $335	-268 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$0.42 - $1.51 $112 - $404	268 New	268 $0
Q1 2020 May 13, 2020	SELL	$0.47 - $1.56 $0 - $1	-1 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.72 - $1.52 $0 - $1	1 New	1 $0

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.